Within the group, Lorraine's research focuses on the synthesis and characterization of biocompatible broad-spectrum virucidal materials. Lorraine completed a Master of Research in Translation Medicine: Molecular Medicine at the University of Manchester. Her project at the time focused on target identification and validation for Non-Small Cell Lung Cancer and was performed under the direction of  Cancer Research UK's Drug Discovery Unit (Manchester Institute). She has also completed the requirements to become a Health and Care Professions Council (HCPC) registered biomedical scientist in infectious disease. Her passions lie in the development of infectious disease therapeutics.